Sat.Apr 19, 2025 - Fri.Apr 25, 2025

article thumbnail

Email Marketing Campaigns: A Valuable Tactic in Pharma Marketing

Pharma Marketing Network

Introduction In the ever-evolving world of healthcare promotion, pharma brands are constantly seeking reliable, cost-effective, and targeted strategies to stay connected with healthcare professionals (HCPs) and patients. Enter email marketing campaigns a digital tactic that’s proving to be more than just effective. But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape?

HIPAA 52
article thumbnail

Many young people want to quit vaping. A new study says medication can help

STAT

The young people who wanted to quit e-cigarettes didn’t necessarily think they were addicted. But they did think nicotine cravings were a problem. When they enrolled in a Massachusetts General Hospital trial, they told researchers they couldn’t study in the library or work at their desks for long before getting the urge to vape. “They really didn’t like that loss of control,” said Eden Evins, director of the addiction center at Mass General.

Hospitals 259
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Antibody treatment demonstrates potential in lupus kidney disease

European Pharmaceutical Review

New Phase III data has demonstrated the potential benefit of the monoclonal antibody obinutuzumab to treat lupus nephritis. This therapy is already approved for B cell malignancies. The REGENCY Phase III clinical trial evaluated 271 adults with active lupus nephritis, a severe complication of lupus that inhibits kidney function. Participants were randomised to receive either obinutuzumab plus mycophenolate mofetil and glucocorticoids as standard therapy, or a placebo plus standard therapy.

111
111
article thumbnail

Pharma and healthcare deals in Q1 2025 remain stable amid shift to scalable global models

Express Pharma

Indias pharma and healthcare sector recorded 71 deals amounting to USD 2.6 billion in Q1 2025, according to the Grant Thornton Bharat Pharma & Healthcare Dealtracker. While this marks a 5 per cent decline in deal volume and a 69 per cent drop in deal value compared to Q4 2024, the report notes continued investor interest. Mergers and acquisitions (M&A) accounted for 57 per cent of the total deal value, while private equity (PE) made up 59 per cent of the overall deal volume.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Almost five million Pharmacy First consultations delivered in first year

The Pharmacist

Almost five million Pharmacy First consultations were delivered in the first year of the service in England, official data has confirmed. The latest data from the NHS Business Services Authority (NHSBSA) shows that contractors in England submitted claims for 4,941,308 Pharmacy First consultations between February 2024 and January 2025. Of those, more than half (2,735,577) […] The post Almost five million Pharmacy First consultations delivered in first year appeared first on The Pharmacist.

59
article thumbnail

STAT+: With the FDA in turmoil, the ‘revolving door’ with industry is spinning faster

STAT

Health and Human Services Secretary Robert F. Kennedy Jr. has railed against what he sees as a “revolving door” between workers at drug companies and the Food and Drug Administration. But his department’s actions now seem to be causing that door to spin ever faster.  Scores of FDA employees are searching for an exit from an agency in turmoil, particularly staff members tasked with reviewing drug applications, according to interviews with former employees and industry re

348
348

More Trending

article thumbnail

ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment

Express Pharma

ENTOD Pharmaceuticals has announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for a new ophthalmic formulation designed to slow the progression of myopia in children aged 6 to 12 years. This marks the first global regulatory approval for this specific treatment strength in paediatric eye care.

59
article thumbnail

Walgreens agrees to pay US up to $350m for illegally filling opioid prescriptions

The Guardian - Pharmaceutical Industry

Drugstore chain settles with DoJ over claims it dispensed millions of unlawful prescriptions for more than a decade Walgreens has agreed to pay up to $350m to settle claims by the US justice department that it illegally filled millions of prescriptions for opioids and other controlled substances. The countrys largest drugstore chain must pay the government $300m, plus an additional $50m if the corporation is sold, transferred or merged before 2032, according to the terms of the settlement reache

article thumbnail

STAT+: Eli Lilly opens a new legal front in its battle against compounded GLP-1s

STAT

Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack — the drugmaker accused two of the companies of engaging in the corporate practice of medicine. To date, Lilly and its rival, Novo Nordisk, have filed dozens of suits against numerous companies involved in compounding versions of semaglutide and tirzepatide, the obesity and diabetes drugs known as

article thumbnail

Pharma Focused Social Media Marketing Plans

Pharma Marketing Network

Introduction Pharma brands are rethinking their digital engagement strategies in 2025. With regulatory scrutiny evolving and audience expectations shifting, social media marketing plans have become a central focus for companies looking to maintain trust while expanding reach. Social platforms are no longer just optional toolsthey’re vital channels for HCP and patient engagement.

59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NICE issues final guidance endorsing Pharming’s APDS therapy

Pharmaceutical Business Review

This recommendation facilitates treating the activated phosphoinositide 3-kinase delta (PI3K) syndrome (APDS) in patients aged 12 years and above. The oral therapy is now accessible and funded in England through the Innovative Medicines Fund and is expected to be funded in Wales within the coming three months. The NICE endorsement is supported by the comprehensive data, including a Phase III clinical trial of leniolisib, which showed significant improvements in immune deficiency and dysregulatio

article thumbnail

Vaping trends stall following regulation announcement

The Pharmacist

There has been a fall in vaping and disposable e-cigarette use following the UK Governments announcement of regulations, a study has found. The research led by a team at University College London (UCL) and published inAddiction used data from the Smoking Toolkit Study, a monthly household survey of adults in England, Wales and Scotland. […] The post Vaping trends stall following regulation announcement appeared first on The Pharmacist.

52
article thumbnail

Opinion: Short-term diet trials are designed to fail

STAT

Imagine a clinical trial with sedentary, overweight adults. One group is assigned to remain sedentary, the other to undergo intensive physical training with daily runs, calisthenics, and sports. After a week or two, the training group would probably feel sore and tired, and their endurance might be reduced. But we wouldn’t conclude that physical activity is bad for health.

362
362
article thumbnail

Reports Document FDA Review Delays: What Drugmakers Should Know Now

FDA Law Blog: Biosimilars

By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

What does Integrated Marketing Communications Mean in Pharma?

Pharma Marketing Network

Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? For brands like Keytruda , Humira , and Ozempic , success isnt just about having a powerful product. Its about delivering consistent, engaging messages across a fragmented media landscape. Much like a symphony that requires every instrument to be in sync, pharma marketers must harmonize every touchpoint to resonate with both healthcare professionals and patien

article thumbnail

Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment

Express Pharma

Disease overview Cholestatic liver disease is a condition that causes liver damage and fibrosis due to bile stasis. It is characterized by the slowing or stalling of bile flow through the hepato-biliary system (liver and bile duct). When bile flow is affected, it backs up into the organs and bloodstream, caus- ing inflammation. The disease is represented by primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), but the pathophysiological pathways that cause bile stasis in bo

article thumbnail

Opinion: The ‘yes, and’ approach to dementia care

STAT

When a person with dementia gets something fundamental wrong — the year it is, your relationship to them — it can be difficult to know what to do. Do you correct them and risk upsetting them? Is it a lie or unethical to go along with it? Ted Johnson, who chairs the Department of Family and Preventive Medicine at the Emory School of Medicine, says that playing along is not only OK; it’s often the best thing for both the patient and the caretaker.

281
281
article thumbnail

MAPPED: Some constituencies have fewer than ten pharmacies

The Pharmacist

Some constituencies in England have fewer than 10 pharmacies to serve their population, new data from the House of Commons Library has revealed. And across England and Wales, the total number of12,204 pharmacies in September 2016 had fallen by 8% to 11,184 in January 2025. The Liberal Democrats, which commissioned the analysis, warned 'pharmacy deserts' […] The post MAPPED: Some constituencies have fewer than ten pharmacies appeared first on The Pharmacist.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Does Referral Marketing Work in Pharma?

Pharma Marketing Network

Introduction In the age of digital disruption and evolving patient expectations, does Referral Marketing hold any real value in the pharmaceutical space? Think about this: when a friend recommends a restaurant, youre far more likely to try it. The same psychology applies in healthcare, though with significantly higher stakes. As pharma brands like Ozempic and Dupixent seek to establish deeper connections with prescribers and patients, referral-based strategies are increasingly being tested acros

HIPAA 52
article thumbnail

Galapagos announces leadership changes amid planned company split

Pharmafile

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been appointed founding CEO of the newly created subsidiary, currently named SpinCo. The subsidiary, which will operate independently following the split, is funded by Galapagos. Gosebruch joins SpinCo with extensive experience in business development and mergers […] The post Galapagos announces leadership changes amid planned company split appeared first on Pharm

64
article thumbnail

Intensive lowering of blood pressure tied to lower dementia risk

STAT

High blood pressure earned its reputation as the silent killer by causing heart attacks, heart failure, and strokes. It’s also been a suspect in dementia. Some studies have hinted at a correlation between lower blood pressure and fewer dementia cases, but they were too small and too short to lend statistical significance to the link. It’s also been noted that people with untreated high blood pressure carry a 42% higher risk of developing dementia.

346
346
article thumbnail

Enhancing Attendee Wellness at Events: Insights from the NHC Event Professionals Affinity Group Meeting

Putting Patients First Blog

Enhancing Attendee Wellness at Events: Insights from the NHC Event Professionals Affinity Group Meeting April 21, 2025 By Racquel Codling, Director, Meetings & Events Conferences and other events can be intense and demanding, leading to stress and burnout for attendees. However, incorporating wellness activities can help mitigate these effects, ensuring attendees feel energized, rejuvenated, and engaged.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

How to Improve your Pharma Network

Pharma Marketing Network

Introduction In a rapidly evolving healthcare landscape, how can your Pharma Network stay ahead of the curve? As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. Much like upgrading an outdated GPS for an unknown journey, refreshing your pharma connections will determine whether your brand thrives or struggles in the new era.

HIPAA 52
article thumbnail

Successful clinical outcomes for drug treating rare stroke condition

Pharmafile

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral haemorrhagic stroke (ICH). This brings the company closer to rolling out the first approved treatment for the devastating condition. The BIRCH trial, which took place with 16 patients with ICH, met both primary safety and […] The post Successful clinical outcomes for drug treating rare stroke condition appeared first on Pharmafile.

59
article thumbnail

Opinion: Employers should continue waiving preventive care out-of-pocket costs regardless of how Supreme Court rules

STAT

On Tuesday, the Supreme Court heard oral arguments in Kennedy v. Braidwood Management , a case in which an employer is arguing that the formation of the U.S. Preventive Services Task Force (USPSTF) violates the Constitution’s appointments clause. The Affordable Care Act (ACA) regulations require that employer-sponsored health plans cover USPSTF-approved preventive care without cost sharing.

267
267
article thumbnail

QbD for biopharmaceutical product lifecycle management

European Pharmaceutical Review

Quality-by-design (QbD) is a systemic risk-management strategy that facilitates the production of safe and consistent drugs. As pharma and biotech companies move towards more complex medicines, it is critical they have contract development and manufacturing organisation (CDMO) partners who can implement QbD principles while maintaining the accelerated timelines required for competitive business.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New leadership role created at RPS as director for England sought

The Pharmacist

The Royal Pharmaceutical Society (RPS) is recruiting for a new director for England after previous postholder Dr James Davies left the role at the end of last year. Applicants for the 80,000-85,000 director for England role must be a pharmacist, an RPS member, and have experience or knowledge of more than one sector in pharmacy […] The post New leadership role created at RPS as director for England sought appeared first on The Pharmacist.

87
article thumbnail

CARBOGEN AMCIS manufacturing license advances services in China

Pharmafile

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing License (DML) from Chinas National Medical Products Administration (NMPA). This marks a significant step in the companys expansion into the Chinese pharma market. The Shanghai site excelled in all regulatory expectations when good manufacturing practices(GMP) […] The post CARBOGEN AMCIS manufacturing license advances services in China appe

59
article thumbnail

Advanced cancers returned to pre-pandemic levels, according to a reassuring report

STAT

Many Americans were forced to  postpone cancer screenings  — colonoscopies, mammograms, and lung scans — for several months in 2020 as Covid-19 overwhelmed doctors and hospitals. But that delay in screening isn’t making a huge impact on cancer statistics, at least none that can be seen yet by experts who track the data.

Hospitals 182
article thumbnail

FDA approves novel therapy for chronic skin condition

European Pharmaceutical Review

For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.

105
105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.